Shares of ITT Inc. (NYSE:ITT – Get Free Report) have earned a consensus recommendation of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]

Truist Financial lowered shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a buy rating to a hold rating in a report released on Tuesday, Marketbeat Ratings reports. The firm currently has $12.00 price objective on the stock, down from their previous price objective of $24.00. IGMS has been the topic of several other research […]

HC Wainwright reiterated their buy rating on shares of Gain Therapeutics (NASDAQ:GANX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $8.00 price target on the stock. GANX has been the topic of several other research reports. Oppenheimer reiterated an outperform rating and set a $8.00 price […]

StockNews.com upgraded shares of QuinStreet (NASDAQ:QNST – Free Report) from a sell rating to a hold rating in a research note issued to investors on Tuesday. QNST has been the subject of a number of other research reports. Craig Hallum boosted their target price on QuinStreet from $22.00 to $25.00 and gave the stock a […]

Scotiabank assumed coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research report released on Monday, Marketbeat.com reports. The brokerage issued a sector outperform rating and a $20.00 price target on the stock. Several other research analysts have also recently issued reports on the stock. Craig Hallum began coverage on shares of […]

HC Wainwright reaffirmed their buy rating on shares of Nyxoah (NASDAQ:NYXH – Free Report) in a research report released on Monday morning, Benzinga reports. They currently have a $18.00 price objective on the stock. A number of other research firms also recently commented on NYXH. Cantor Fitzgerald dropped their price objective on Nyxoah from $17.00 […]

Shares of nVent Electric plc (NYSE:NVT – Get Free Report) have been assigned an average rating of “Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have issued ratings on the stock in […]

IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target lowered by Guggenheim from $25.00 to $20.00 in a research report sent to investors on Tuesday, Benzinga reports. Guggenheim currently has a buy rating on the stock. Other analysts have also issued reports about the stock. Truist Financial lowered shares of IGM Biosciences from a […]

Cantor Fitzgerald reaffirmed their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a report issued on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $600.00 price objective on the stock. Other research analysts have also issued research reports about the stock. Royal Bank of Canada boosted their target price on shares […]

Needham & Company LLC reiterated their hold rating on shares of ResMed (NYSE:RMD – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. A number of other analysts also recently issued reports on the company. Oppenheimer downgraded ResMed from an outperform rating to a market perform rating in a research note […]

Banner (NASDAQ:BANR – Get Free Report) had its price objective increased by stock analysts at Raymond James from $62.00 to $65.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has an “outperform” rating on the financial services provider’s stock. Raymond James’ price target suggests a potential upside […]

Amerant Bancorp (NASDAQ:AMTB – Get Free Report) had its price target lowered by investment analysts at Raymond James from $27.00 to $25.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Raymond James’ price objective indicates a potential upside of 23.89% from the stock’s previous close. […]

HC Wainwright reissued their buy rating on shares of Immunovant (NASDAQ:IMVT – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $51.00 price objective on the stock. IMVT has been the subject of a number of other research reports. Oppenheimer dropped their target price on Immunovant from $50.00 to $46.00 […]

Needham & Company LLC reiterated their buy rating on shares of Alight (NYSE:ALIT – Free Report) in a research report report published on Monday, Benzinga reports. They currently have a $9.00 price objective on the stock. Several other equities analysts also recently issued reports on ALIT. Wedbush cut their price objective on Alight from $12.00 […]

StockNews.com upgraded shares of Willdan Group (NASDAQ:WLDN – Free Report) from a buy rating to a strong-buy rating in a report issued on Tuesday morning. WLDN has been the subject of a number of other research reports. Wedbush began coverage on Willdan Group in a research report on Tuesday, September 3rd. They issued an outperform […]

CareDx (NASDAQ:CDNA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. Other research analysts also recently issued reports about the company. Wells Fargo & Company assumed coverage on CareDx in a report on Tuesday, August 27th. They issued an “underweight” […]